Cargando…

Cardiac hypertrophy is negatively regulated by miR-541

Heart failure is a leading cause of death in aging population. Cardiac hypertrophy is an adaptive reaction of the heart against cardiac overloading, but continuous cardiac hypertrophy is able to induce heart failure. We found that the level of miR-541 was decreased in angiotensin II (Ang-II) treated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, F, Li, N, Long, B, Fan, Y-Y, Liu, C-Y, Zhou, Q-Y, Murtaza, I, Wang, K, Li, P-F
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2014
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5424117/ https://www.ncbi.nlm.nih.gov/pubmed/24722296 http://dx.doi.org/10.1038/cddis.2014.141

Ejemplares similares

miR-199a impairs autophagy and induces cardiac hypertrophy through mTOR activation
por: Li, Z, et al.
Publicado: (2017)

Study on Genetic Variance of miR-541 in Type 1 Diabetes
por: Han, Bei, et al.
Publicado: (2012)

miR-874 regulates myocardial necrosis by targeting caspase-8
por: Wang, K, et al.
Publicado: (2013)

miR-208a in Cardiac Hypertrophy and Remodeling
por: Huang, Xing-Huai, et al.
Publicado: (2021)

The lncRNA Plscr4 Controls Cardiac Hypertrophy by Regulating miR-214
por: Lv, Lifang, et al.
Publicado: (2017)

miR-541 Contributes to Microcystin-LR-Induced Reproductive Toxicity through Regulating the Expression of p15 in Mice
por: Meng, Xiannan, et al.
Publicado: (2016)

miR-217 Promotes Cardiac Hypertrophy and Dysfunction by Targeting PTEN
por: Nie, Xiang, et al.
Publicado: (2018)

Targeting miR-30d reverses pathological cardiac hypertrophy
por: Li, Jin, et al.
Publicado: (2022)

Up‐regulation of miR‐195 contributes to cardiac hypertrophy‐induced arrhythmia by targeting calcium and potassium channels
por: Xuan, Lina, et al.
Publicado: (2020)

Overexpression of miR-221 in sudden death with cardiac hypertrophy patients
por: Kakimoto, Yu, et al.
Publicado: (2018)

MiR-30-Regulated Autophagy Mediates Angiotensin II-Induced Myocardial Hypertrophy
por: Pan, Wei, et al.
Publicado: (2013)

Cardiomyocyte overexpression of miR-27b induces cardiac hypertrophy and dysfunction in mice
por: Wang, Jian, et al.
Publicado: (2012)

Up‐regulation of circRNA_0068481 promotes right ventricular hypertrophy in PAH patients via regulating miR‐646/miR‐570/miR‐885
por: Guo, Hong‐mei, et al.
Publicado: (2021)

Long non‐coding RNA cardiac hypertrophy‐associated regulator governs cardiac hypertrophy via regulating miR‐20b and the downstream PTEN/AKT pathway
por: Zhang, Mingyu, et al.
Publicado: (2019)

miR-21 upregulation exacerbates pressure overload-induced cardiac hypertrophy in aged hearts
por: Chang, Wei-Ting, et al.
Publicado: (2022)

Resveratrol Ameliorates Cardiac Hypertrophy by Down‐regulation of miR‐155 Through Activation of Breast Cancer Type 1 Susceptibility Protein
por: Fan, Yuhua, et al.
Publicado: (2016)

TEAD1/4 exerts oncogenic role and is negatively regulated by miR-4269 in gastric tumorigenesis
por: Zhou, Y, et al.
Publicado: (2017)

miR-410 and miR-495 Are Dynamically Regulated in Diverse Cardiomyopathies and Their Inhibition Attenuates Pathological Hypertrophy
por: Clark, Amanda L., et al.
Publicado: (2016)

Enhancer of Zeste homolog 2 (EZH2) is overexpressed in recurrent nasopharyngeal carcinoma and is regulated by miR-26a, miR-101, and miR-98
por: Alajez, N M, et al.
Publicado: (2010)

MiR-34c suppresses tumor growth and metastasis in nasopharyngeal carcinoma by targeting MET
por: Li, Y-Q, et al.
Publicado: (2015)

Zoophycos macroevolution since 541 Ma
por: Zhang, Li-Jun, et al.
Publicado: (2015)

NFAT4-dependent miR-324-5p regulates mitochondrial morphology and cardiomyocyte cell death by targeting Mtfr1
por: Wang, K, et al.
Publicado: (2015)

miR-30d, miR-181a and miR-199a-5p cooperatively suppress the endoplasmic reticulum chaperone and signaling regulator GRP78 in cancer
por: Su, S-F, et al.
Publicado: (2013)

Involvement of miR-30c in resistance to doxorubicin by regulating YWHAZ in breast cancer cells
por: Fang, Y., et al.
Publicado: (2014)

miR‐541 suppresses proliferation and invasion of squamous cell lung carcinoma cell lines via directly targeting high‐mobility group AT‐hook 2
por: Xu, Li, et al.
Publicado: (2018)

miR-541 serves as a prognostic biomarker of osteosarcoma and its regulatory effect on tumor cell proliferation, migration and invasion by targeting TGIF2
por: Liu, Chunlei, et al.
Publicado: (2020)

Circulating MiR-133a as a Biomarker Predicts Cardiac Hypertrophy in Chronic Hemodialysis Patients
por: Wen, Ping, et al.
Publicado: (2014)

miR-183-5p attenuates cerebral ischemia injury by negatively regulating PTEN
por: Zhu, Li, et al.
Publicado: (2020)

LINC00638 promotes the progression of non-small cell lung cancer by regulating the miR-541-3p/IRS1/PI3K/Akt axis
por: Zhang, Juan, et al.
Publicado: (2023)

MiR-582-5p/miR-590-5p targeted CREB1/CREB5–NF-κB signaling and caused opioid-induced immunosuppression in human monocytes
por: Long, X, et al.
Publicado: (2016)

Genetic Variants miR-126, miR-146a, miR-196a2, and miR-499 in Polycystic Ovary Syndrome
por: Li, R., et al.
Publicado: (2022)

MiR-216b is involved in pathogenesis and progression of hepatocellular carcinoma through HBx-miR-216b-IGF2BP2 signaling pathway
por: Liu, F-y, et al.
Publicado: (2015)

Genome-wide screen identified let-7c/miR-99a/miR-125b regulating tumor progression and stem-like properties in cholangiocarcinoma
por: Lin, K-Y, et al.
Publicado: (2016)

miR-541-3p enhances the radiosensitivity of prostate cancer cells by inhibiting HSP27 expression and downregulating β-catenin
por: He, Zhenhua, et al.
Publicado: (2021)

miR-218 Involvement in Cardiomyocyte Hypertrophy Is Likely through Targeting REST
por: Liu, Jing-Jing, et al.
Publicado: (2016)

miR-374 promotes myocardial hypertrophy by negatively regulating vascular endothelial growth factor receptor-1 signaling
por: Lee, Jong Sub, et al.
Publicado: (2017)

MicroRNAs miR-221 and miR-222: a new level of regulation in aggressive breast cancer
por: Shah, Maitri Y, et al.
Publicado: (2011)

MALAT1 regulates hypertrophy of cardiomyocytes by modulating the miR-181a/HMGB2 pathway
por: Chen, Feng, et al.
Publicado: (2022)

mir15a/mir16‐1 cluster and its novel targeting molecules negatively regulate cardiac hypertrophy
por: Guo, Hongchang, et al.
Publicado: (2020)

miR-139-5p inhibits isoproterenol-induced cardiac hypertrophy by targetting c-Jun
por: Ming, Su, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_uc8tjrgnvnqr74nrqi0nvthovk